Although it was not the primary goal, proteinuria was observed to be significantly reduced by treatment in 40% of patients, thus proving that TNF-α may play a crucial role in the disease in a subgroup of FSGS patients (135). Here, TNF is linked to focal segmental glomerulosclerosis.